I agree that this site is using cookies. You can find further informations here.
X
Abdelmagid, Maymona
19  results:
?
1

CALR mutation burden in essential thrombocythemia and disea..:

Guglielmelli, Paola ; Szuber, Natasha ; Gangat, Naseema...
Blood.  143 (2024)  13 - p. 1310-1314 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Prognostic impact of SF3B1 mutation and multilineage dyspla..:

Farrukh, Faiqa ; Abdelmagid, Maymona ; Mangaonkar, Abhishek...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
3

Molecular predictors of response and survival following IDH..:

Gangat, Naseema ; McCullough, Kristen ; Abdelmagid, Maymona...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
4

Venetoclax duration (14 vs. 21 vs. 28 days) in combination ..:

Karrar, Omer ; Abdelmagid, Maymona ; Rana, Masooma...
American Journal of Hematology.  99 (2023)  2 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
5

Venetoclax and hypomethylating agent combination therapy in..:

Gangat, Naseema ; Karrar, Omer ; Iftikhar, Moazah...
American Journal of Hematology.  99 (2023)  2 - p. 193-202 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Granularity in disease classification impacts survival pred..:

Tefferi, Ayalew ; Abdelmagid, Maymona ; Al‐Kali, Aref...
American Journal of Hematology.  99 (2023)  1 - p. 21-27 , 2023
Link: https://doi.org/10.1002/..
 
?
7

ABO blood group type and risk of venous thrombosis in essen..:

Karrar, Omer S. ; Abdelmagid, Maymona ; Vannucchi, Alessandro M....
British Journal of Haematology.  202 (2023)  3 - p. 699-703 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Black African-American patients with primary myelofibrosis:..:

Gangat, Naseema ; Kuykendall, Andrew ; Al Ali, Najla...
Blood Advances.  7 (2023)  12 - p. 2694-2698 , 2023
Link: https://doi.org/10.1182/..
 
?
9

IDH1/2 inhibitor monotherapy in blast‐phase myeloproliferat..:

Gangat, Naseema ; Ajufo, Helen ; Abdelmagid, Maymona...
British Journal of Haematology.  203 (2023)  3 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
10

Lenalidomide therapy for primary myelodysplastic syndromes ..:

Singh, Amritpal ; Al‐Kali, Aref ; Foran, James M....
American Journal of Hematology.  97 (2022)  10 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
11

Pure (acute) erythroid leukemia: morphology, immunophenotyp..:

Reichard, Kaaren K. ; Tefferi, Ayalew ; Abdelmagid, Maymona...
Blood Cancer Journal.  12 (2022)  11 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
12

TP53 mutations and variant allele frequency in myelodysplas..:

Fleti, Farah ; Chan, Onyee ; Singh, Amritpal...
American Journal of Hematology.  98 (2023)  4 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
13

Real-world experience with ponatinib therapy in chronic pha..:

Abdelmagid, Maymona G. ; Al-Kali, Aref ; Litzow, Mark R....
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
14

Blast phase myeloproliferative neoplasm with prior exposure..:

Abdelmagid, Maymona G. ; Al-Kali, Aref ; Begna, Kebede H....
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
15

Midostaurin therapy for advanced systemic mastocytosis: May..:

Singh, Amritpal ; Al‐Kali, Aref ; Begna, Kebede H....
American Journal of Hematology.  97 (2022)  5 - p. 630-637 , 2022
Link: https://doi.org/10.1002/..
 
1-15